Literature DB >> 31583188

Distribution of ischemic strokes in patients with atrial fibrillation: The FibStroke Study.

Jussi Jaakkola1, Päivi Hartikainen1, Tuomas O Kiviniemi1, Ilpo Nuotio1, Antti Palomäki1, Juha E K Hartikainen1, Antti Ylitalo1, Pirjo Mustonen1, K E Juhani Airaksinen1.   

Abstract

BACKGROUND: We aimed to determine the relative frequency of affected cerebrovascular territories in patients with atrial fibrillation (AF) suffering an ischemic stroke.
METHODS: Altogether, 1,976 patients who suffered their first-ever ischemic stroke during 2003-2012 and were diagnosed with AF either before or within 30 days after the event were included in this retrospective multicenter cohort study. Strokes were classified radiographically to be located either within the anterior or the posterior cerebrovascular territory, and the effect of the CHA2DS2-VASc score, oral anticoagulant (OAC) use, and timing of AF diagnosis on lesion localization was determined.
RESULTS: The median age of the patients was 78.4 (interquartile range: 71.7-84.2) years, 1,137 (57.5%) of them were women, their mean CHA2DS2-VASc score was 3.5 (95% confidence interval: 3.4-3.5), 656 (33.2%) were receiving OAC drugs, and altogether, 1,450 (73%) had a previous AF diagnosis. The localization of ischemic lesions between the anterior and the posterior cerebrovascular territories was not affected by the timing of AF diagnosis (p = 0.46), use of OACs (p = 0.70), or the CHA2DS2-VASc score (p = 0.10). Within the anterior territory, altogether 774 strokes (53.2%) were located in the left hemisphere and 3 (0.2%) were bilateral. The timing of AF diagnosis (p = 0.84), use of OACs (p = 0.90), or the CHA2DS2-VASc score (p = 0.21) did not affect the location of the ischemic lesion between the hemispheres.
CONCLUSIONS: The timing of AF diagnosis, use of OAC drugs, or the CHA2DS2-VASc score did not affect the distribution of ischemic strokes. Anterior territory strokes were slightly more often located within the left hemisphere.
© 2019 American Academy of Neurology.

Entities:  

Year:  2019        PMID: 31583188      PMCID: PMC6745749          DOI: 10.1212/CPJ.0000000000000683

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN: 2163-0402


  17 in total

1.  Cerebral Embolism as a Cause of Stroke and Transient Ischemic Attack.

Authors:  John Stirling; Kazuhiro Muramatsu; Toshitaka Shirai
Journal:  Echocardiography       Date:  1996-09       Impact factor: 1.724

2.  Strokes after cardioversion of atrial fibrillation--The FibStroke study.

Authors:  Antti Palomäki; Pirjo Mustonen; Juha E K Hartikainen; Ilpo Nuotio; Tuomas Kiviniemi; Antti Ylitalo; Päivi Hartikainen; Heidi Lehtola; Riho Luite; K E Juhani Airaksinen
Journal:  Int J Cardiol       Date:  2015-10-20       Impact factor: 4.164

3.  Role of a stroke data bank in evaluating cerebral infarction subtypes: patterns and outcome of 1,776 consecutive patients from the Besançon stroke registry.

Authors:  T Moulin; L Tatu; F Vuillier; E Berger; D Chavot; L Rumbach
Journal:  Cerebrovasc Dis       Date:  2000 Jul-Aug       Impact factor: 2.762

4.  Right-left propensity and lesion patterns between cardiogenic and aortogenic cerebral embolisms.

Authors:  Hye-Jin Kim; Jong-Min Song; Sun U Kwon; Bum-Joon Kim; Duk-Hyun Kang; Jae-Kwan Song; Jong S Kim; Dong-Wha Kang
Journal:  Stroke       Date:  2011-06-09       Impact factor: 7.914

5.  Right-side propensity of cardiogenic emboli in acute ischemic stroke with atrial fibrillation.

Authors:  Kwang-Yeol Park; Yong Bum Kim; Pil-Wook Chung; Heui-Soo Moon; Bum Chun Suh; Kyung Jae Yoon; Yong-Taek Lee
Journal:  Scand Cardiovasc J       Date:  2014-12       Impact factor: 1.589

6.  Difference in recognition of right and left hemispheric stroke.

Authors:  Christian Foerch; Bjoern Misselwitz; Matthias Sitzer; Klaus Berger; Helmuth Steinmetz; Tobias Neumann-Haefelin
Journal:  Lancet       Date:  2005 Jul 30-Aug 5       Impact factor: 79.321

7.  Atrial fibrillation, stroke risk, and warfarin therapy revisited: a population-based study.

Authors:  Staffan Björck; Bo Palaszewski; Leif Friberg; Lennart Bergfeldt
Journal:  Stroke       Date:  2013-08-27       Impact factor: 7.914

8.  Is there a side predilection for cerebrovascular disease?

Authors:  Sergio A Rodríguez Hernández; Abraham A Kroon; Martin P J van Boxtel; Werner H Mess; Jan Lodder; Jelle Jolles; Peter W de Leeuw
Journal:  Hypertension       Date:  2003-06-16       Impact factor: 10.190

9.  Underuse of anticoagulation in stroke patients with atrial fibrillation--the FibStroke Study.

Authors:  A Palomäki; P Mustonen; J E K Hartikainen; I Nuotio; T Kiviniemi; A Ylitalo; P Hartikainen; K E J Airaksinen
Journal:  Eur J Neurol       Date:  2015-08-11       Impact factor: 6.089

10.  Hemispheric differences in ischemic stroke: is left-hemisphere stroke more common?

Authors:  Vishnumurthy Shushrutha Hedna; Aakash N Bodhit; Saeed Ansari; Adam D Falchook; Latha Stead; Kenneth M Heilman; Michael F Waters
Journal:  J Clin Neurol       Date:  2013-04-04       Impact factor: 3.077

View more
  2 in total

1.  Microembolic Signals in Arteries of the Base of the Brain after Ischemic Stroke.

Authors:  E Yu Medvedkova; A B Berdalin; E V Orlova; V G Lelyuk
Journal:  Bull Exp Biol Med       Date:  2022-06-23       Impact factor: 0.804

2.  Association of stroke lesion shape with newly detected atrial fibrillation - Results from the MonDAFIS study.

Authors:  Bernardo Crespo Pimentel; Thies Ingwersen; Karl Georg Haeusler; Eckhard Schlemm; Nils D Forkert; Deepthi Rajashekar; Pauline Mouches; Alina Königsberg; Paulus Kirchhof; Claudia Kunze; Serdar Tütüncü; Manuel C Olma; Michael Krämer; Dominik Michalski; Andrea Kraft; Timolaos Rizos; Torsten Helberg; Sven Ehrlich; Darius G Nabavi; Joachim Röther; Ulrich Laufs; Roland Veltkamp; Peter U Heuschmann; Bastian Cheng; Matthias Endres; Götz Thomalla
Journal:  Eur Stroke J       Date:  2022-05-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.